REUSCH, CLAUDIA EDELTRUDE
REUSCH, CLAUDIA EDELTRUDE
Mostra
records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.013 secondi).
Evaluation of symmetric dimethylarginine and creatinine in dogs with primary hypoadrenocorticism receiving long-term mineralocorticoid replacement therapy
2022 Casado Diaz J.I.; Sieber-Ruckstuhl N.S.; Boretti F.S.; Fracassi F.; Reusch C.E.
Feline plasma adrenocorticotropic hormone: validation of a chemiluminescent assay and concentrations in cats with hypercortisolism, primary hypoadrenocorticism and other diseases
2021 Tardo A.M.; Reusch C.E.; Galac S.; Fornetti S.; Tirolo A.; Golinelli S.; Shehdula D.; Fracassi F.
Feline plasma adrenocorticotropic hormone: validation of a chemiluminescent assay and concentrations in cats with hypercortisolism, primary hypoadrenocorticism and other diseases
2021 Tardo A.M.; Reusch C.E.; Galac S.; Fornetti S.; Tirolo A.; Golinelli S.; Shehdula D.; Fracassi F.
Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release
2020 Kramer A.L.; Riederer A.; Fracassi F.; Boretti F.S.; Sieber-Ruckstuhl N.S.; Lutz T.A.; Contiero B.; Zini E.; Reusch C.E.
Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment
2017 Reusch, C. E.; Fracassi, F.; Sieber-Ruckstuhl, N. S.; Burkhardt, W. A.; Hofer-Inteeworn, N.; Schuppisser, C.; Stirn, M.; Hofmann-Lehmann, R.; Boretti, F. S.